Search Results
Dr. Harrison on Subcutaneous Daratumumab and Isatuximab in Myeloma
Isatuximab for multiple myeloma - promising results and next steps
Analyzing isatuximab in quadruplet combinations in transplant-ineligible multiple myeloma
Final results of isatuximab in combinations to treat r/r MM
An update on GMMG HD7: Isa-RVd vs RVd & lenalidomide-isatuximab vs lenalidomide maintenance in NDMM
Dr. Chaudhry on DRd Triplet in Transplant-Ineligible Multiple Myeloma
Real-world safety & efficacy of isatuximab-pomalidomide-dexamethasone in R/R multiple myeloma
Isatuximab: a ‘next-generation monoclonal antibody’
IKEMA: isatuximab addition to Kd improves depth of response in myeloma
Where isatuximab may fit in the treatment paradigm for relapsed/refractory multiple myeloma
Highlighting Therapeutic Options in Later Lines for Multiple Myeloma
Overview of a Phase II clinical trial of isatuximab
